Scolaris Content Display Scolaris Content Display

Table 1. Summary of methodological quality

Trial

How rand/concealed

Blinding

Size (Na/Nr)

Attrition (%)

Premens Exacerbation

Psych. disorder

Diagnosis

Other omissions

Relation to protocol

Magill
1995

Adequate

Adequate

Large

93/141

High

(34%)

Adequate

Adequate

Adequate

None

Did conform

Vanselow
1996

Adequate

In doubt

Small

22/39

High

(44%)

Adequate

Adequate

Adequate

None

Did conform

Figuras y tablas -
Table 1. Summary of methodological quality
Table 2. Interventions

trial

route

vehicle

dose in mg

frequency

beginning

ending

treatment free days

cycles

Magill 1995

vaginal or rectal

Suppocire
(a mixture of mono, di and tri‐glycerides and polyoxyethylene glyceride)

400

twice a day

14 days before next expected menses

menses

none

4 either placebo or progesterone
in parallel design

Vanselow 1996

vaginal
and oral

arachis oil in soft gelatine capsules

oral
100

2 x 100

vaginal
2 x 100

each morning

and each night

at night

3 days after ovulation

not reported

not recorded

1,2 oral progesterone with vaginal placebo
or oral placebo with vaginal progesterone
or vaginal and oral placebos
3,4 different combination
5,6 remaining combination

Figuras y tablas -
Table 2. Interventions
Table 3. The nature of primary outcomes in included studies

Trial

Scales used

When applied

By whom

Number of items

Degrees of severity

Data Used

Statistic

Significance tests

Comments

Magill
1995

Diary cards

daily

participants

symptoms selected by participants

4 point scale

baseline score ie mean of eligible symptoms' scores

reductions in baseline scores for each cycle in each group

medians and interquartiles of baseline scores for each group

medians and interquartiles of reductions in baseline scores for each cycle of each group

Wilcoxon rank sum test

unsuitable treatment of ordinal data

Vaneslow
1996
1

Menstrual Distress Questionnaire
MDQ

on day 26

trialists

47 in eight groups

6 point scale

sum of scores for second month

means and SDs

ANOVA with Bonferroni correction
Fisher's Planned Least Significant Difference

unsuitable treatment of ordinal data

SDs larger than means

2

Beck Depression Inventory
BDI

on day 26

trialists

21

4 point scale

sum of scores for second month

means and SDs

unsuitable treatment of ordinal data

3

Spielberger STAI

on day 26

trialists

40

4

sum of scores for second month

means and SDs

unsuitable treatment of ordinal data

Figuras y tablas -
Table 3. The nature of primary outcomes in included studies